Cullinan Therapeutics CGEM
NASDAQ CGEM
$10.78 -0.57 (-5.02%)
As of: Nov 12, 2026 · 11:11 AM EST

Cullinan Therapeutics (CGEM) Interest & Investment Income (2020 - 2026)

Updated

Cullinan Therapeutics (CGEM) posted Interest & Investment Income of $3.65 million for Q2 2026, down 38.4% from $5.92 million a year earlier and down 11.0% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Interest & Investment Income (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Cullinan Therapeutics was $17.45 million, down 38.5% year-over-year; for FY2025, it was $22.21 million, down 25.1% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 90.4% (FY2020 to FY2025).
  • In prior years, Cullinan Therapeutics' Interest & Investment Income was $29.66 million in FY2024 (+37.1%), $21.63 million in FY2023 (+227.1%), $6.61 million in FY2022 and $477,000 in FY2021 (-46.3%).
  • The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q4 2022.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last five quarters, with an average decline of 11.9% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 663.6%; the weakest was Q3 2025, with a decline of 39.3%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $4.1 million (Q1 2026), $4.62 million (Q4 2025) and $5.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Cullinan Therapeutics 722.60 Mn -1.13 Bn - 3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.29 Mn
Jun 30, 2026 3.65 Mn
Mar 31, 2026 4.10 Mn
Dec 31, 2025 4.62 Mn
Sep 30, 2025 5.09 Mn
Jun 30, 2025 5.92 Mn
Mar 31, 2025 6.58 Mn
Dec 31, 2024 7.51 Mn
Sep 30, 2024 8.38 Mn
Jun 30, 2024 8.07 Mn
Mar 31, 2024 5.69 Mn
Dec 31, 2023 5.92 Mn
Sep 30, 2023 5.88 Mn
Jun 30, 2023 5.32 Mn
Mar 31, 2023 4.51 Mn
Dec 31, 2022 3.36 Mn
Sep 30, 2022 2.35 Mn
Jun 30, 2022 697,000.00
Mar 31, 2022 197,000.00
Dec 31, 2021 137,000.00
API Access

Cullinan Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CGEM&period=max&api_key=YOUR_API_KEY